On the other hand, ADRB2 variants were linked to insulin resistance, hyperleptinemia, obesity, and T2D, while ADRB3 variants have been associated with dyslipidaemia, obesity, and MetS [36]. This evidence concerns the gene ADRB2 and metabolic syndrome.